Early microglial activation and peripheral inflammation in dementia with Lewy bodies.

作者: Ajenthan Surendranathan , Li Su , Elijah Mak , Luca Passamonti , Young T Hong

DOI: 10.1093/BRAIN/AWY265

关键词: PathogenesisCaudate nucleusPathologyDementiaMedicineProinflammatory cytokineLewy bodyInflammationCytokineDementia with Lewy bodies

摘要: Inflammation is increasingly recognized as part of the pathology neurodegenerative conditions such Alzheimer's disease and Parkinson's disease, but its role in dementia with Lewy bodies remains unclear. Using multimodal imaging peripheral cytokine analysis, we therefore investigated central inflammation this common form dementia. Nineteen participants probable 16 similarly aged controls underwent 3 T MRI PET 11C-PK11195, a marker microglial activation vivo. Peripheral blood inflammatory cytokines were also measured all subjects, well an additional 10 controls, using Mesoscale Human Cytokine 36 plex panel assays for high sensitivity c-reactive protein, tumour necrosis factor receptor 1, IL-34, YKL-40 (chitinase-3-like protein 1) colony stimulating 1. To test presence vivo amyloid, 11C-Pittsburgh compound B was performed body participants. Microglial elevated subjects mild when compared to those moderate/severe impairment, where severity indexed by cognitive performance on revised Addenbrooke's Cognitive Examination. In patients, strong correlations found between 11C-PK11195 non-displaceable binding potential several regions including caudate nucleus (R = 0.83, P 0.00008) cuneus 0.77, 0.0005). Several altered patients macrophage protein-3 (P 0.001), IL-17A 0.008) IL-2 0.046) reduced IL-8 0.024). There no correlation cortical standardized uptake value ratio clinical features, regional or levels. Nor there any potentials ratios. Our findings provide evidence both changes bodies, occurring early key known be associated pathology, before declining cognition declines. Raised cell function further suggest adaptive immune system pathogenesis disease.

参考文章(71)
Zhen Fan, Aren A. Okello, David J. Brooks, Paul Edison, Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease Brain. ,vol. 138, pp. 3685- 3698 ,(2015) , 10.1093/BRAIN/AWV288
Z. Walker, D. C. Costa, R. W.H. Walker, L. Lee, G. Livingston, E. Jaros, R. Perry, I. McKeith, C. L.E. Katona, Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. ,vol. 62, pp. 1568- 1572 ,(2004) , 10.1212/01.WNL.0000123248.39847.1D
Vanessa Brochard, Béhazine Combadière, Annick Prigent, Yasmina Laouar, Aline Perrin, Virginie Beray-Berthat, Olivia Bonduelle, Daniel Alvarez-Fischer, Jacques Callebert, Jean-Marie Launay, Charles Duyckaerts, Richard A. Flavell, Etienne C. Hirsch, Stéphane Hunot, Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease Journal of Clinical Investigation. ,vol. 119, pp. 182- 192 ,(2008) , 10.1172/JCI36470
Satoshi Minoshima, Norman L. Foster, Anders A. F. Sima, Kirk A. Frey, Roger L. Albin, David E. Kuhl, Alzheimer's disease versus Dementia with Lewy bodies : Cerebral metabolic distinction with autopsy confirmation Annals of Neurology. ,vol. 50, pp. 358- 365 ,(2001) , 10.1002/ANA.1133
Kejal Kantarci, Val J. Lowe, Bradley F. Boeve, Stephen D. Weigand, Matthew L. Senjem, Scott A. Przybelski, Dennis W. Dickson, Joseph E. Parisi, David S. Knopman, Glenn E. Smith, Tanis J. Ferman, Ronald C. Petersen, Clifford R. Jack, Multimodality imaging characteristics of dementia with Lewy bodies Neurobiology of Aging. ,vol. 33, pp. 2091- 2105 ,(2012) , 10.1016/J.NEUROBIOLAGING.2011.09.024
SHIN-YA KAWASHIRI, ATSUSHI KAWAKAMI, NAOKI IWAMOTO, KEITA FUJIKAWA, TOSHIYUKI ARAMAKI, MAMI TAMAI, KAZUHIKO ARIMA, MAKOTO KAMACHI, SATOSHI YAMASAKI, HIDEKI NAKAMURA, TOSHIYUKI TSURUMOTO, MASAFUMI KONO, HIROYUKI SHINDO, HIROAKI IDA, TOMOKI ORIGUCHI, KATSUMI EGUCHI, Proinflammatory Cytokines Synergistically Enhance the Production of Chemokine Ligand 20 (CCL20) from Rheumatoid Fibroblast-like Synovial Cells in vitro and Serum CCL20 Is Reduced in vivo by Biologic Disease-modifying Antirheumatic Drugs The Journal of Rheumatology. ,vol. 36, pp. 2397- 2402 ,(2009) , 10.3899/JRHEUM.090132
I. R. A. Mackenzie, Activated microglia in dementia with Lewy bodies Neurology. ,vol. 55, pp. 132- 134 ,(2000) , 10.1212/WNL.55.1.132
Shu-Hua Huang, Chiung-Chih Chang, Chun-Chung Lui, Nai-Ching Chen, Chen-Chang Lee, Pei-Wen Wang, Ching-Fen Jiang, Cortical metabolic and nigrostriatal abnormalities associated with clinical stage-specific dementia with Lewy bodies. Clinical Nuclear Medicine. ,vol. 40, pp. 26- 31 ,(2015) , 10.1097/RLU.0000000000000620
Kazuhiro Imamura, Nozomi Hishikawa, Makoto Sawada, Toshiharu Nagatsu, Mari Yoshida, Yoshio Hashizume, Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains Acta Neuropathologica. ,vol. 106, pp. 518- 526 ,(2003) , 10.1007/S00401-003-0766-2
Martí Colom-Cadena, Ellen Gelpi, Sara Charif, Olivia Belbin, Rafael Blesa, Maria J. Martí, Jordi Clarimon, Alberto Lleó, Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology. ,vol. 72, pp. 1203- 1212 ,(2013) , 10.1097/NEN.0000000000000018